17-beta HSD14 / HSD17B14 antibody
Principal name
17-beta HSD14 / HSD17B14 antibody
Alternative names for 17-beta HSD14 / HSD17B14 antibody
17-beta-hydroxysteroid dehydrogenase 14, DHRS10, SDR3, Dehydrogenase/reductase SDR family member 10, 17-beta-hydroxysteroid dehydrogenase DHRS10, Retinal short-chain dehydrogenase/reductase retSDR3
Gene ID
51171 (HSD17B14)
Ncbi ID
Available reactivities
Available hosts
Available applications
ELISA (detection) (E(detection)), Western blot / Immunoblot (WB)
Background of 17-beta HSD14 / HSD17B14 antibody
- Kit Component:
- - KN202531G1, HSD17B14 gRNA vector 1 in pCas-Guide vector
- KN202531G2, HSD17B14 gRNA vector 2 in pCas-Guide vector
- KN202531D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Grimwood J., et al. (2004), Nature., 428: 529-535.
Lukacik P., et al. (2007). Biochem. J., 402: 419-427.
Western Blot analysis of HSD17B14 expression in transfected 293T cell line (H00051171-T01) by HSD17B14 MaxPab polyclonal antibody.Lane 1: DHRS10 transfected lysate(29.7 KDa).Lane 2: Non-transfected lysate.
Western Blot analysis of HSD17B14 expression in transfected 293T cell line (H00051171-T01) by HSD17B14 MaxPab polyclonal antibody.Lane 1: DHRS10 transfected lysate(29.7 KDa).Lane 2: Non-transfected lysate.
Human Liver; WB Suggested Anti-HSD17B14 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:1562500. Positive Control: Human Liver; HSD17B14 antibody - middle region (ARP56865_P050) in Human Liver cells using Western Blot
Human Small Intestine; WB Suggested Anti-HSD17B14 Antibody Titration: 0.2-1 ug/ml. Positive Control: Human Small Intestine; HSD17B14 antibody - N-terminal region (ARP56864_P050) in Human Small Intestine cells using Western Blot
Recombinant human HSD17B14, 1-270aa, His-tagged
WB Suggested Anti-HSD17B14 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1:1562500; Positive Control: Human Liver
WB Suggested Anti-HSD17B14 Antibody Titration: 0.2-1 ug/ml; Positive Control: Human Small Intestine
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA345048 | 17-beta HSD14 / HSD17B14 antibody |
||||||
| Rabbit Polyclonal Anti-HSD17B14 Antibody - middle region | |||||||
 |
Rabbit | IgG | Purified | Hu | WB |
50 µg /
€360.00
|
|
| OriGene Technologies, Inc. | |||||||
| TA345049 | 17-beta HSD14 / HSD17B14 antibody |
||||||
| Rabbit Polyclonal Anti-HSD17B14 Antibody - N-terminal region | |||||||
 |
Rabbit | IgG | Purified | Can, Ms, Por, Rb, Rt | WB |
50 µg /
€360.00
|
|
| OriGene Technologies, Inc. | |||||||
CRISPR
| Catalog No. | Species | Donor Vector | |
|---|---|---|---|
| KN202531 | HSD17B14 - human gene knockout kit via CRISPR |
||
 |
Human | GFP-Puro |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN202531BN | HSD17B14 - human gene knockout kit via CRISPR |
||
|
Human | mBFP-Neo |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN202531LP | HSD17B14 - human gene knockout kit via CRISPR |
||
|
Human | Luciferase-Puro |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
| KN202531RB | HSD17B14 - human gene knockout kit via CRISPR |
||
|
Human | RFP-BSD |
1 kit /
€1,290.00
|
| OriGene Technologies, Inc. | |||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP302531 | 17-beta HSD14 / HSD17B14 |
||||
| Recombinant protein of human hydroxysteroid (17-beta) dehydrogenase 14 (HSD17B14) | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€438.00
|
|
| OriGene Technologies, Inc. | |||||
|
|||||
| AR09738PU-L | 17-beta HSD14 / HSD17B14 (1-270, His-tag) |
||||
 |
Human | Purified | > 95 % | E. coli |
0.5 mg /
€750.00
|
| Acris Antibodies GmbH | |||||
 +1 additional image |
|||||
| AR09738PU-N | 17-beta HSD14 / HSD17B14 (1-270, His-tag) |
||||
|
Human | Purified | > 95 % | E. coli |
0.1 mg /
€300.00
|
| Acris Antibodies GmbH | |||||
| +1 additional image |
|||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY414089 | HSD17B14 overexpression lysate |
|
|
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Human Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RC202531L2V | Lenti ORF particles, HSD17B14 (mGFP-tagged) - Human hydroxysteroid (17-beta) dehydrogenase 14 (HSD17B14), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€989.00
|
|
| OriGene Technologies, Inc. | ||
| RC202531L1V | Lenti ORF particles, HSD17B14 (Myc-DDK tagged) - Human hydroxysteroid (17-beta) dehydrogenase 14 (HSD17B14) , 200 uL, >10^7 TU/mL |
|
|
200 µl /
€886.00
|
|
| OriGene Technologies, Inc. | ||
